Form 4: Surgery Partners Executive Sells Shares to Cover Tax Obligations

Jennifer Baldock, Chief Admin & Dev Officer of Surgery Partners, sold 2,318 shares of common stock on March 4, 2024, to cover tax obligations related to vesting restricted stock.

Summary

• On March 4, 2024, Jennifer Baldock, Chief Admin & Dev Officer of Surgery Partners, sold 2,318 shares of the company's common stock.
• The sale was executed at a weighted average price of $30.73 per share.
• This transaction was to satisfy tax withholding obligations related to the vesting of restricted stock on March 2, 2024.
• Following the transaction, Baldock directly owns 185,241 shares of Surgery Partners' common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to an insider stock sale for tax purposes, which is neither particularly positive nor negative.

Industry Context

Form 4 filings are a routine part of the US stock market and are required by the SEC to provide transparency into the transactions of company insiders. This allows investors to see if company executives are buying or selling shares of their own company, which can be an indicator of their confidence in the company's future prospects. However, sales to cover tax obligations are common and do not necessarily indicate a lack of confidence.

Stakeholder Impact

• The sale has a minimal impact on shareholders as it is a small transaction by an individual officer to cover tax obligations.

Key Dates